IP Library Granted Patent US 12,065,414
Granted Patent B2
US 12,065,414 · App. 17/465,197 · Granted Aug 20, 2024

Process for preparation of isoxazoline substituted benzamide compound

Inventors: Kumar Kamlesh Singh (Gujarat, IN); Sanjay Jagdish Desai (Gujarat, IN); Kuldeep Natwarlal Jain (Gujarat, IN); Jitesh Amratlal Desai (Gujarat, IN); Sarvil Dhirajbhai Patel (Gujarat, IN)
Assignee: ZYDUS LIFESCIENCES LIMITED
C07D261/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,065,414
App. No.
17/465,197
Granted
Aug 20, 2024
Kind
B2
Abstract

The invention relates to process for the preparation of isoxazoline-substituted benzamide compound and intermediates thereof. The invention also relates to process for the preparation of Fluralaner and intermediates thereof.

Claims (14)

1. A process for the preparation of fluralaner, the process comprising:

(a) reacting a compound of Formula (VI) with a compound of Formula (VII),

to obtain a compound of Formula (V),

wherein M is Cs,

wherein the reaction is performed in the presence of cesium carbonate;

(b) converting the compound of Formula (V) into a compound of Formula (IV) or its reactive derivative,

wherein the reaction is performed in the presence of boron trifluoride etherate and acetic anhydride;

(c) reacting the compound of Formula (IV) or its reactive derivative with 2-Amino-N-(2,2,2-trifluoroethyl)acetamide, or salts thereof to obtain a compound of Formula (II); and

(d) reacting the compound of Formula (II) with hydroxylamine, or salts thereof to obtain fluralaner.

2. The process according to claim 1 , wherein the reaction at step (a) is performed in the presence of water, C 1 -C 4 -alcohols, 1,4-dioxane, acetonitrile, toluene, dimethyl formamide, or mixtures thereof.

3. The process according to claim 1 , wherein the reaction at step (c) is performed in the presence of a coupling reagent selected from N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) or N,N′-diisopropylcarbodiimide (DIC).

4. The process according to claim 1 , wherein the reactions at step (c) and step (d) are performed in the presence of a base comprises one or more of alkali metal hydroxides selected from sodium hydroxide, potassium hydroxide, and lithium hydroxide, alkali metal carbonates selected from sodium carbonate, potassium carbonate, lithium carbonate, and cesium carbonate, alkali metal bicarbonate selected from sodium bicarbonate, and potassium bicarbonate, triethylamine, pyridine, N,N-dimethyl aminopyridine, 1,8-diazabicyclo-(5.4.0)-7-undecene (DBU), 1,5-diazabicyclo(4.3.0)non-5-ene (DBN), 4-(dimethylamino)pyridine, N,N-dimethylaniline, imidazole, and tributylamine.

5. The process according to claim 1 , wherein the reaction at step (d) is performed in the presence of a solvent selected from methanol, ethanol, propanol, and butanol, benzene, toluene, xylene, hexane, heptane, cyclohexane, diethylether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4-dioxane, ethyl acetate, ethyl propionate, N,N-dimethylformamide, acetonitrile, and dimethylsulfoxide.

6. The process according to claim 1 , wherein the process comprises preparation of fluralaner without isolating the compounds of Formula (IV) and (II).

Assignments (2)
CHANGE OF NAME Recorded Dec 7, 2023
From: CADILA HEALTHCARE PRIVATE LIMITED
To: ZYDUS LIFESCIENCES LIMITED
Reel/Frame 065790/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: SINGH, KUMAR KAMLESH; DESAI, SANJAY JAGDISH; JAIN, KULDEEP NATWARLAL; DESAI, JITESH AMRATLAL; PATEL, SARVIL DHIRAJBHAI
To: CADILA HEALTHCARE LIMITED
Reel/Frame 057711/0659 →
Priority Claims (1)
IN 202021037955 · Sep 3, 2020 · national
Continuity (1)
Related Publication 20220064130A1 · Mar 3, 2022